Finance

Beta
Lists
TTOO:OTCMKTS
T2 Biosystems Inc
US$0,00060
+20,00%
(+0,00010) 1D
30 āšĄāšī.āš–., 16 āŧ‚āšĄāš‡ 0 āš™āšēāš—āšĩ 00 āš§āšīāš™āšēāš—āšĩ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTOO...
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
āŧ‘āŧ–,āŧ˜āŧ“ āšžāšąāš™
Avg. vol.
āŧ–,āŧ—āŧ“ āšžāšąāš™
Volume
āŧ•,āŧ˜āŧ‘ āšžāšąāš™
52-wk high
US$0,16
52-wk low
US$0,00
Beta
āŧ,āŧ˜āŧ˜
Shares outstanding
āŧ’āŧ˜,āŧāŧ” āšĨāŧ‰āšēāš™
No. of employees
āŧ‘āŧ‘āŧ“
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
āŧ‘āŧ–,āŧ˜āŧ“ āšžāšąāš™
Avg. vol.
āŧ–,āŧ—āŧ“ āšžāšąāš™
Volume
āŧ•,āŧ˜āŧ‘ āšžāšąāš™
52-wk high
US$0,16
52-wk low
US$0,00
Beta
āŧ,āŧ˜āŧ˜
Shares outstanding
āŧ’āŧ˜,āŧāŧ” āšĨāŧ‰āšēāš™
No. of employees
āŧ‘āŧ‘āŧ“
News stories
From sources across the web
TheaterMania
TheaterMania
·
58 āš™āšēāš—āšĩāšāŧˆāš­āš™
AndrÃĐ De Shields Rings the New York Stock Exchange Closing Bell
Yahoo Finance
Yahoo Finance
·
41 āš™āšēāš—āšĩāšāŧˆāš­āš™
AI firm tied to bankrupt crypto lender files for Nasdaq listing
Seeking Alpha
Seeking Alpha
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
3 things to look out for on Wednesday (SP500:)
The Motley Fool
The Motley Fool
·
13 āš™āšēāš—āšĩāšāŧˆāš­āš™
The Vanguard S&P 500 ETF Is Riskier Than You Think. This Could Be a Better Option.
About T2 Biosystems Inc
CEO-
Employees113
Founded2006
HeadquartersLexington, āšĄāšēāšŠāšēāšŠāšđāŧ€āšŠāšąāš”, āšŠāš°āšŦāš°āšĨāšąāš”
SectorBiotechnology
Websiteinvestors.t2biosystems.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
āš—.āš§. 2023
āšĄ.āš™. 2024
āšĄāšī.āš–. 2024
āš.āš. 2024
Revenue
-
2,06 āšĨāŧ‰āšēāš™
1,95 āšĨāŧ‰āšēāš™
1,98 āšĨāŧ‰āšēāš™
Cost of goods sold
-
-
6,05 āšĨāŧ‰āšēāš™
6,75 āšĨāŧ‰āšēāš™
Cost of revenue
-
-
6,05 āšĨāŧ‰āšēāš™
6,75 āšĨāŧ‰āšēāš™
Research and development expenses
-
-
-
22,00 āšžāšąāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
5,47 āšĨāŧ‰āšēāš™
5,38 āšĨāŧ‰āšēāš™
Operating expense
-
-
5,47 āšĨāŧ‰āšēāš™
5,40 āšĨāŧ‰āšēāš™
Total operating expenses
-
-
11,53 āšĨāŧ‰āšēāš™
12,15 āšĨāŧ‰āšēāš™
Operating income
-
-
-9,58 āšĨāŧ‰āšēāš™
-10,16 āšĨāŧ‰āšēāš™
Other non operating income
-
-
1,09 āšĨāŧ‰āšēāš™
414,00 āšžāšąāš™
EBT including unusual items
-
-
-8,96 āšĨāŧ‰āšēāš™
-10,12 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-
-
-8,96 āšĨāŧ‰āšēāš™
-10,12 āšĨāŧ‰āšēāš™
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-8,96 āšĨāŧ‰āšēāš™
-10,12 āšĨāŧ‰āšēāš™
Net profit margin
-
-
-459,17%
-509,67%
Earnings per share
-
-2,66
-0,66
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-478,00 āšžāšąāš™
-370,00 āšžāšąāš™
Net interest expenses
-
-
-478,00 āšžāšąāš™
-370,00 āšžāšąāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-9,51 āšĨāŧ‰āšēāš™
-10,10 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
21,00 āšžāšąāš™
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer